It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Alzheimer’s drug furor highlights U.S. health system’s failures

Commentary / World Jun 14, 2021

Alzheimer’s drug furor highlights U.S. health system’s failures

The FDA didn’t deny that the clinical-trial evidence was poor. It simply ignored that problem and used different reasoning to grant the drug "accelerated approval.”

U.S. FDA faces mounting criticism over Alzheimer's drug approval

World / Science & Health | ANALYSIS Jun 11, 2021

U.S. FDA faces mounting criticism over Alzheimer's drug approval

by Deena Beasley and Julie Steenhuysen

The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.

Indians still battling impacts of COVID-19 now burdened with medical debt

Asia Pacific Jun 11, 2021

Indians still battling impacts of COVID-19 now burdened with medical debt

by Bibhudatta Pradhan and Vrishti Beniwal

Even before the pandemic struck, India’s out-of-pocket expenses on health care were among the highest in the world.

Fixing the broken pandemic financing system

Commentary / World Jun 10, 2021

Fixing the broken pandemic financing system

by David Miliband, Elizabeth Radin and Christopher Eleftheriades

The devastation caused by COVID-19 has underscored what experts have said for years: our national, regional and global systems are grossly inadequate for detecting and containing outbreaks.

Eisai sees potential of new Alzheimer's drug but costs remain concern

Business Jun 9, 2021

Eisai sees potential of new Alzheimer's drug but costs remain concern

The approval by the U.S. Food and Drug Administration of the drug Aduhelm raised hopes, but patients can expect to be charged $56,000 a year.

Biggest vaccine-maker’s problems keep world short of COVID-19 shots

World Jun 9, 2021

Biggest vaccine-maker’s problems keep world short of COVID-19 shots

by Chris Kay and P.R. Sanjai

The Serum Institute of India's travails have become a key illustration of how the effort to inoculate against COVID-19 has failed the developing world.

Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug

National / Science & Health Jun 8, 2021

Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug

by Robert Langreth

The approval appears to signal a fundamental shift in the way the FDA thinks about Alzheimer's disease, which could have lasting ramifications for other drugs in the pipeline.

The world should learn from India’s COVID-19 cataclysm

Commentary / World Jun 7, 2021

The world should learn from India’s COVID-19 cataclysm

by Mihir Sharma

Strategies that kept the pandemic at bay in 2020 won’t necessarily work in 2021.

Lessons from the pandemic

Commentary / World Jun 6, 2021

Lessons from the pandemic

by Cesar Chelala

Most countries are lagging far behind and new, concerted and more generous efforts by the richest nations are needed to control the pandemic at a global level.

In Japan, the light at the end of the pandemic's tunnel remains distant

National | FOCUS Jun 4, 2021

In Japan, the light at the end of the pandemic's tunnel remains distant

by Ryusei Takahashi

The vaccine rollout may be accelerating, but the nation remains far away from a return to normalcy.

Chinese drugmakers take aim at lucrative U.S. anti-cancer market

Business | FOCUS Jun 4, 2021

Chinese drugmakers take aim at lucrative U.S. anti-cancer market

In recent years, medicines that free the immune system to attack tumors have become blockbusters in a $150 billion global market.

COVID-19 vaccines to be available to all under 65 in Japan at same time

National / Science & Health May 30, 2021

COVID-19 vaccines to be available to all under 65 in Japan at same time

The central government is also considering administering U.S. pharmaceutical company Moderna Inc.'s vaccine, which was approved in Japan in May.

« 1 … 29 30 31 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times